/
DCF Valuation
Base-case fair value
$119.55
Intrinsic $159.40 · 25% MOS
Current price: $219.13
Base-case summary
Our base-case DCF for AbbVie Inc. (ABBV) projects 10 years of free cash flow growth at 2.0% for years 1–5 and 1.0% for years 6–10, anchored to a default 8% growth assumption, then applies a 2.5% perpetual growth rate and a 8.0% discount rate. Starting from $20.0B in trailing free cash flow, this produces an intrinsic value of $159.40 per share. A 25% safety margin gives a fair value of $119.55, suggesting the stock is currently 45% overvalued against the $219.13 market price.
See 3 scenarios side by side
Conservative, Base, and Optimistic fair values, plus the sensitivity matrix and FCF history. Free account.
Model inputs
TTM Free Cash Flow
$20.0B
Cash & equivalents
$9.4B
Total debt
$72.9B
Shares outstanding
1.8B